Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma. (Q33503261)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

main subject

phase II clinical trial

0 references

author

Michael Grossbard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

9

L M Nadler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

P Fidias

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

J Kinsella

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

J O'Toole

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

J M Lambert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

W A Blattler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

D Esseltine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

G Braman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

K C Anderson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

language of work or name

English

0 references

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

2 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

509-515

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695966%20AND%20SRC:MED&resulttype=core&format=json

The treatment of multiple myeloma

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00799.X

The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00799.X

An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00799.X

Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00799.X

Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00799.X

The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00799.X

A cytotoxicity assay utilizing a fluorescent dye that determines accurate surviving fractions of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00799.X

Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00799.X

Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00799.X